Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Van Andel Institute Establishes Global Epigenetics Research Hub

Published: Wednesday, February 26, 2014
Last Updated: Wednesday, February 26, 2014
Bookmark and Share
Institute announces the establishment of a global epigenetics research hub, tapping into a hot-button research topic responsible for new and innovative approaches to personalized cancer therapy.

Epigenetics is widely regarded as the most significant new area of cancer research; it is the study of heritable changes in gene activity which are not caused by changes in the DNA sequence. The term epigenetics literally means “above” or “on top of” genetics, referring to external modifications to DNA that can turn genes “on” or “off.”

Leading this effort is Peter A. Jones Ph.D., D.Sc., Director of Research, Chief Scientific Officer of Van Andel Research Institute. Dr. Jones is a renowned researcher with more than 40 years’ experience in academia in the field of biomolecular research. Dr. Jones’ recent research has focused on epigenetics and how epigenetic therapies might benefit those living with cancer. He is based in the global headquarters of Van Andel Institute in Grand Rapids, Michigan and is driving the focus of epigenetic research among the Institute’s research partners in the U.S., U.K., Europe, Asia and around the world.

Dr. Jones’ aggressive blueprint for progress includes developing a consortium of five academic institutions – four in the U.S. and one abroad – which will carry on the work of developing epigenetic therapies that can be applied to human beings. The concept of collaboration plays a primary role in Dr. Jones’ strategy of creating a focus on epigenetics at the Institute. It is a notion that Dr. Jones has cultivated throughout his career, working alongside diverse teams of researchers, geneticists, chemists, oncologists, surgeons and assorted specialists.

“With the appointment of Dr. Jones, a visionary leader in biomedical research, Van Andel Institute is now a global stronghouse in epigenetics, one of the most significant fields in cancer research,” said David Van Andel, Chairman and CEO, Van Andel Institute. “We are embracing this field of study, and will extol epigenetics to a hurting world that is hungry for answers. At Van Andel Institute, we bank on sound science that precedes us, and embrace others who share our vision, and that includes ‘disruptors’ who are not afraid to say that we are impatient for new breakthroughs. Paired with our translational research that is speeding the delivery of new therapies from research bench to bedside, the establishment of an epigenetics hub with Dr. Jones at the helm will impact millions of lives, developing new epigenetic therapies for cancer and neurodegenerative diseases.”

Dr. Jones plans to bolster the Institute’s impressive research portfolio in cancer, neurodegenerative and other diseases as he continues his translational research in epigenetics. “Van Andel Institute is dedicated to changing the course of biomedical research and as I lead our new epigenetics hub, I have already begun to build a robust clinical program, am recruiting outstanding scientists and plan to continue to ensure exceptional science,” said Dr. Jones.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

TOPLESS Plants Provide Clues to Human Molecular Interactions
Scientists at Van Andel Research Institute have revealed an important molecular mechanism in plants that has significant similarities to certain signaling mechanisms in humans, which are closely linked to early embryonic development and to diseases such as cancer.
Tuesday, July 28, 2015
Prognostic Role Found for miR-21 Expression in Triple-Negative Breast Cancer
Findings suggest measurement of changes in the tumor microenvironment are important in this heterogeneous group.
Wednesday, December 03, 2014
Van Andel Study Provides New Details of Fundamental Cellular Process
Study of plant hormone could have far-reaching implications for cell biology and disease research.
Wednesday, January 25, 2012
Van Andel Research Institute Findings Provide More Complete Picture of Kidney Cancer
Two recent studies distinguish cancer subtypes and provide promising new drug targets, which could pave the way for better treatments.
Tuesday, January 03, 2012
TGen Affiliate, Van Andel Research Institute, Joins with Spectrum Health and Oncology Group
Cancer patients in West Michigan will soon have the opportunity to access new drugs being developed to fight their disease due to a partnership being formed in Grand Rapids.
Friday, July 30, 2010
Van Andel Institute Cuts Ribbon on $178 Million Expansion
New building creates capacity for 550 new jobs and expanded cancer and neurodegenerative disease research.
Wednesday, December 09, 2009
VAI Researchers Find Long Awaited Key to Creating Drought Resistant Crops
Findings published in the journal Nature could help engineer hardier plants and have implications for stress disorders in humans.
Monday, December 07, 2009
Determining the Structure of Nuclear Receptor has Implications for a Host of Diseases
VAI finding provides a basis for drug design for diseases related to heart and blood vessel development, human embryo development and female infertility.
Thursday, September 18, 2008
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
Diagnostic Test Developed for Enterovirus D68
researchers at Washington University School of Medicine in St. Louis have developed a diagnostic test to quickly detect enterovirus D68 (EV-D68), a respiratory virus that caused unusually severe illness in children last year.
How a Kernel Got Naked and Corn Became King
Ten thousand years ago, a golden grain got naked, brought people together and grew to become one of the top agricultural commodities on the planet.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
New Material Opens Possibilities for Super-Long-Acting Pills
A pH-responsive polymer gel could create swallow able devices, including capsules for ultra-long drug delivery.
How To Keep Your Rice Arsenic-Free
Researchers at Queen’s University Belfast have made a breakthrough in discovering how to lower worrying levels of arsenic in rice that is eaten all over the world.
New Tool For Investigating RNA Gone Awry
A new technology – called “Sticky-flares” – developed by nanomedicine experts at Northwestern University offers the first real-time method to track and observe the dynamics of RNA distribution as it is transported inside living cells.
Computer Model Could Explain how Simple Molecules Took First Step Toward Life
Two Brookhaven researchers developed theoretical model to explain the origins of self-replicating molecules.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!